The evolution of resistance to traditional platinum-based anticancer drugs has compelled
researchers to investigate the cytostatic properties of alternative transition metal-based …

The structural features of copper (II), nickel (II), cobalt (II) and zinc (II) complexes with the
antimicrobial drugs quinolones and non-steroidal anti-inflammatory drugs (NSAIDs) as …

Four Co (III) complexes containing substituted acetyl coumarin Schiff bases have been
synthesized and structurally characterized using IR, UV–visible, 1H nuclear magnetic …

Inorganic complexes are versatile platforms for the development of potent and selective
pharmaceutical agents. Cobalt possesses a diverse array of properties that can be …

Over the past few decades, the realm of inorganic medicinal chemistry has been dominated
by the study of the anti-cancer properties of transition metal complexes, particularly those …

Copper (II) complexes with the non-steroidal antiinflammatory drug flufenamic acid (Hfluf) in
the presence of N, N-dimethylformamide (DMF) or nitrogen donor heterocyclic ligands (2 …

The nonsteroidal anti‐inflammatory drugs (NSAIDs) make up a great group of drugs that
provide benefits in the prevention of cancers. Coordinated metal ions with NSAIDs provide …

Cobalt (II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid in the
presence or absence of nitrogen-donor heterocyclic ligands (2, 2′-bipyridine, 1, 10 …

New anticancer ruthenium (II/III) complexes [RuCl2 (DMSO) 2 (Hapbim)](1) and [RuCl3
(DMSO)(Hapbim)](2)(Hapbim= 2-aminophenyl benzimidazole) have been synthesized and …

After the serendipitous discovery of cisplatin, a platinum-based drug with chemotherapeutic
effects, an incredible amount of research in the area of coordination chemistry has been …